Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination

Tuesday, August 11, 2020 1 min read

Key Takeaway: Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination

Full Press Release Details

Immutep Granted United States Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination.